Helen Bartlett
Helen works closely with clients of all sizes to secure and maintain patent protection for their innovations. With a background in biochemistry, she understands the intricacies of their technologies and advises on commercial IP strategies that support their wider business goals.
Helen advises clients across the life sciences and pharmaceutical industries, from universities and spin-outs to multinational pharmaceutical companies. She helps these companies develop and maintain commercially relevant IP strategies.
Her experience includes working on cases before the EPO’s Opposition Divisions and Boards of Appeal. She also contributed to Potter Clarkson’s first case before the Unified Patent Court (UPC).
- Advising clients on global patent strategy to support commercial objectives
- Drafting and prosecuting patent applications covering complex biotech and therapeutic inventions
- Working on high-profile cases before the EPO’s Opposition Divisions and Boards of Appeal and the UPC
- UK and European Patent Attorney
- MBiochem, Molecular and Cellular Biochemistry, University of Oxford
- Moss Prize (2019): Highest combined mark in UK Patent Law and International Patent Law foundation exams
- Keith Farwell Prize (2020): Highest mark in the UK foundation exam in Trade Mark Law
About Helen
Experience
Areas of expertise
Qualifications
Testimonials
Awards
How We Live Our Values: Excellence
For me, the decisions clients make about their IP strategy must be driven by their commercial goals. The IP strategy must align with the business plan to get the most value out of their IP.
At Potter Clarkson, we advise not just on drafting and filing patents, but also on navigating third-party issues, preparing for investment, due diligence, and contentious matters. That breadth of expertise and commercial focus is what sets us apart and why we’re able to help clients protect and maximise the value of their innovation. I really enjoy working here because it’s the full package in one place.
In My Own Words
When I left university, I wanted to do something that still used science but with a more commercial focus. I really enjoy working with a variety of clients and helping them solve their IP challenges. It’s especially rewarding to see the technologies we’ve helped protect make a tangible difference in the real world.
